Decision-making and breast cancer clinical trials. How experience challenges attitudes

Contemporary Clinical Trials

Volumn 28, Issue 6, 2007, Pages 684-694

  Mancini, Julien ^a,b,c   Genève, Jean ^d   Dalenc, Florence ^e   Genre, Dominique ^a   Monnier, Alain ^f   Kerbrat, Pierre ^g   Largillier, Rémy ^h   Serin, Daniel ⁱ   Rios, Maria ^j   Roché, Henri ^e   Jimenez, Marta ^d   Tarpin, Carole ^a   the Patients' Committee for Clinical trials of the Ligue Nationale, ^k   Julian Reynier, Claire ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c TIMONE HOSPITAL   (France)

^d FNCLCC   (France)

^e INSTITUT CLAUDIUS REGAUD   (France)

^f Centre Hospitalier André Boulloche   (France)

^g Eugene Marquis Comprehensive Cancer Center   (France)

^h CENTRE ANTOINE LACASSAGNE   (France)

ⁱ Sainte Catherine Institute   (France)

^j CRLCC Alexis Vautrin   (France)

^k LNCC   (France)

more..

Author keywords

Breast neoplasms; Decision making; Patient preferences; Personal Autonomy; Randomised controlled trials; Trial participation

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL;

ADULT; ALTRUISM; ARTICLE; BREAST CANCER; CANCER STAGING; CLINICAL RESEARCH; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DEMOGRAPHY; EXPERIENCE; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; METASTASIS; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; PATIENT ATTITUDE; PATIENT PARTICIPATION; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME; WOMEN'S HEALTH;

ADULT; ATTITUDE; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; DECISION MAKING; FEMALE; FRANCE; HEALTH CARE SURVEYS; HUMANS; MIDDLE AGED; PATIENT PARTICIPATION; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 34848928399     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2007.03.001     Document Type: Article

References (37)

1. Cassileth B.R. Clinical trials: time for action. J Clin Oncol 21 (2003) 765-766
2. Ross S., Grant A., Counsell C., et al. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol 52 (1999) 1143-1156
3. Ellis P.M. Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Ann Oncol 11 (2000) 939-945
4. Mills E.J., Seely D., Rachlis B., et al. Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol 7 (2006) 141-148
5. Cox K., and McGarry J. Why patients don't take part in cancer clinical trials: an overview of the literature. Eur J Cancer Care (Engl) 12 (2003) 114-122
6. Fayter D., McDaid C., Ritchie G., et al. A systematic review of the barriers, modifiers and benefits involved in participation in cancer clinical trials (2006), University of York Centre for Reviews and Dissemination (CRD), York
7. McDonald A.M., Knight R.C., Campbell M.K., et al. What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials 7 (2006) 9
8. Sharp L., Cotton S.C., Alexander L., et al. Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears). Clin Trials 3 (2006) 431-442
9. Thornton H., and Dixon-Woods M. Recruitment of women into trials. Lancet 359 (2002) 164-165
10. Tournoux C., Katsahian S., Chevret S., and Levy V. Factors influencing inclusion of patients with malignancies in clinical trials. Cancer 106 (2006) 258-270
11. Peppercorn J.M., Weeks J.C., Cook E.F., and Joffe S. Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet 363 (2004) 263-270
12. Vist G.E., Hagen K.B., Devereaux P.J., et al. Systematic review to determine whether participation in a trial influences outcome. BMJ 330 (2005) 1175
13. Joffe S., and Weeks J.C. Views of American oncologists about the purposes of clinical trials. J Natl Cancer Inst 94 (2002) 1847-1853
14. Jenkins V., and Fallowfield L. Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer 82 (2000) 1783-1788
15. Fleissig A., Jenkins V., and Fallowfield L. Results of an intervention study to improve communication about randomised clinical trials of cancer therapy. Eur J Cancer 37 (2001) 322-331
16. Degner L.F., Kristjanson L.J., Bowman D., et al. Information needs and decisional preferences in women with breast cancer. JAMA 277 (1997) 1485-1492
17. Silverman W.A., and Altman D.G. Patients' preferences and randomised trials. Lancet 347 (1996) 171-174
18. Ellis P.M., Butow P.N., Tattersall M.H., et al. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol 19 (2001) 3554-3561
19. Llewellyn-Thomas H.A., McGreal M.J., Theil E.C., et al. Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med 32 (1991) 35-42
20. Llewellyn-Thomas H.A., McGreal M.J., and Thiel E.C. Cancer patients' decision making and trial-entry preferences: the effects of "framing" information about short-term toxicity and long-term survival. Med Decis Making 15 (1995) 4-12
21. Bonneterre J., Roche H., Kerbrat P., et al. Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial. J Clin Oncol 23 (2005) 2686-2693
22. Zubrod C., Schneiderman M., and Frei E.J. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard an triethylene thiophosphoramide. J Chronic Dis 11 (1960) 7-33
23. Hann D., Winter K., and Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 46 (1999) 437-443
24. Micallef J., McGlangeaud-Freudenthal N., Aurran Y., and Julian-Reynier C. Measurement of anxiety state in women: a short-form scale. Rev Epidemiol Sante Publique 46 (1998) 383-389
25. Bredart A., Razavi D., Robertson C., et al. A comprehensive assessment of satisfaction with care: preliminary psychometric analysis in French, Polish, Swedish and Italian oncology patients. Patient Educ Couns 43 (2001) 243-252
26. Julian-Reynier C., Geneve J., Dalenc F., et al. Satisfaction with breast cancer care in women treated within and outside a clinical trial: prospective assessment through a multi-center survey. J Clin Oncol 23 16S (2005) 8127 [Meeting Abstracts]
27. Stryker J.E., Wray R.J., Emmons K.M., et al. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret. Patient Educ Couns 63 (2006) 104-109
28. Hietanen P., Aro A.R., Holli K., and Absetz P. Information and communication in the context of a clinical trial. Eur J Cancer 36 (2000) 2096-2104
29. Stevens T., and Ahmedzai S.H. Why do breast cancer patients decline entry into randomised trials and how do they feel about their decision later: a prospective, longitudinal, in-depth interview study. Patient Educ Couns 52 (2004) 341-348
30. Jenkins V., Fallowfield L., and Cox A. The preferences of 600 patients for different descriptions of randomisation. Br J Cancer 92 (2005) 807-810
31. Ellis P.M., Dowsett S.M., Butow P.N., and Tattersall M.H. Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinic. Health Expect 2 (1999) 33-43
32. Cassileth B.R., Lusk E.J., Miller D.S., and Hurwitz S. Attitudes toward clinical trials among patients and the public. JAMA 248 (1982) 968-970
33. Wright J.R., Whelan T.J., Schiff S., et al. Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision. J Clin Oncol 22 (2004) 4312-4318
34. Mills N., Metcalfe C., Ronsmans C., et al. A comparison of socio-demographic and psychological factors between patients consenting to randomisation and those selecting treatment (the ProtecT study). Contemp Clin Trials 27 (2006) 413-419
35. Gotay C.C. Increasing trial generalizability. J Clin Oncol 24 (2006) 846-847
36. Simon M.S., Du W., Flaherty L., et al. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. J Clin Oncol 22 (2004) 2046-2052
37. Murthy V.H., Krumholz H.M., and Gross C.P. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291 (2004) 2720-2726